Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2018, Article ID 1625414, 16 pages
https://doi.org/10.1155/2018/1625414
Research Article

Selenoprotein S Attenuates Tumor Necrosis Factor-α-Induced Dysfunction in Endothelial Cells

1Department of Endocrinology, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, China
2Department of Immunology, Dalian Medical University, Dalian, Liaoning 116044, China

Correspondence should be addressed to Jianling Du; moc.361@ncgnilnaijud

Received 30 September 2017; Revised 22 December 2017; Accepted 8 January 2018; Published 1 April 2018

Academic Editor: Adrian Doroszko

Copyright © 2018 Siyuan Cui et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. A. Gimbrone Jr and G. García-Cardeña, “Endothelial cell dysfunction and the pathobiology of atherosclerosis,” Circulation Research, vol. 118, no. 4, pp. 620–636, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. C. M. Sena, A. M. Pereira, and R. Seiça, “Endothelial dysfunction—a major mediator of diabetic vascular disease,” Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol. 1832, no. 12, pp. 2216–2231, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Butt, G. Dwivedi, A. Blann, O. Khair, and G. Y. H. Lip, “Endothelial dysfunction: methods of assessment & implications for cardiovascular diseases,” Current Pharmaceutical Design, vol. 16, no. 31, pp. 3442–3454, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Favero, C. Paganelli, B. Buffoli, L. F. Rodella, and R. Rezzani, “Endothelium and its alterations in cardiovascular diseases: life style intervention,” BioMed Research International, vol. 2014, Article ID 801896, 28 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. C. M. Steyers 3rd and F. J. Miller Jr, “Endothelial dysfunction in chronic inflammatory diseases,” International Journal of Molecular Sciences, vol. 15, no. 12, pp. 11324–11349, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Naya, T. Tsukamoto, K. Morita et al., “Plasma interleukin-6 and tumor necrosis factor-α can predict coronary endothelial dysfunction in hypertensive patients,” Hypertension Research, vol. 30, no. 6, pp. 541–548, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Brånén, L. Hovgaard, M. Nitulescu, E. Bengtsson, J. Nilsson, and S. Jovinge, “Inhibition of tumor necrosis factor-α reduces atherosclerosis in apolipoprotein E knockout mice,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 11, pp. 2137–2142, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Zhang, Y. Park, J. Wu et al., “Role of TNF-α in vascular dysfunction,” Clinical Science, vol. 116, no. 3, pp. 219–230, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Grover-Páez and A. B. Zavalza-Gómez, “Endothelial dysfunction and cardiovascular risk factors,” Diabetes Research and Clinical Practice, vol. 84, no. 1, pp. 1–10, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Matsuzawa, R. R. Guddeti, T. G. Kwon, L. O. Lerman, and A. Lerman, “Treating coronary disease and the impact of endothelial dysfunction,” Progress in Cardiovascular Diseases, vol. 57, no. 5, pp. 431–442, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Ye, Y. Shibata, C. Yun, D. Ron, and T. A. Rapoport, “A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol,” Nature, vol. 429, no. 6994, pp. 841–847, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Du, H. Liu, and K. Huang, “Influence of SelS gene silence on β-mercaptoethanol-mediated endoplasmic reticulum stress and cell apoptosis in HepG2 cells,” Biochimica et Biophysica Acta (BBA) - General Subjects, vol. 1800, no. 5, pp. 511–517, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Ye, F. Fu, X. Li, J. Yang, and H. Liu, “Selenoprotein S is highly expressed in the blood vessels and prevents vascular smooth muscle cells from apoptosis,” Journal of Cellular Biochemistry, vol. 117, no. 1, pp. 106–117, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Gao, N. R. F. Hannan, S. Wanyonyi et al., “Activation of the selenoprotein SEPS1 gene expression by pro-inflammatory cytokines in HepG2 cells,” Cytokine, vol. 33, no. 5, pp. 246–251, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Gao, K. Walder, T. Sunderland et al., “Elevation in Tanis expression alters glucose metabolism and insulin sensitivity in H4IIE cells,” Diabetes, vol. 52, no. 4, pp. 929–934, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Walder, L. Kantham, J. S. McMillan et al., “Tanis: a link between type 2 diabetes and inflammation?” Diabetes, vol. 51, no. 6, pp. 1859–1866, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Zeng, S. Du, J. Zhou, and K. Huang, “Role of SelS in lipopolysaccharide-induced inflammatory response in hepatoma HepG2 cells,” Archives of Biochemistry and Biophysics, vol. 478, no. 1, pp. 1–6, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Fradejas, C. del Carmen Serrano-Pérez, P. Tranque, and S. Calvo, “Selenoprotein S expression in reactive astrocytes following brain injury,” Glia, vol. 59, no. 6, pp. 959–972, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Yu, L. Men, J. Wu et al., “The source of circulating selenoprotein S and its association with type 2 diabetes mellitus and atherosclerosis: a preliminary study,” Cardiovascular Diabetology, vol. 15, no. 1, p. 70, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Bian, H. Li, Q. Zhou, C. Ni, Y. Zhang, and F. Yan, “Human β-defensin 3 reduces TNF-α-induced inflammation and monocyte adhesion in human umbilical vein endothelial cells,” Mediators of Inflammation, vol. 2017, Article ID 8529542, 11 pages, 2017. View at Publisher · View at Google Scholar · View at Scopus
  21. H.-J. Wang, Y.-L. Huang, Y.-Y. Shih, H.-Y. Wu, C.-T. Peng, and W.-Y. Lo, “MicroRNA-146a decreases high glucose/thrombin-induced endothelial inflammation by inhibiting NAPDH oxidase 4 expression,” Mediators of Inflammation, vol. 2014, Article ID 379537, 12 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Siragusa and I. Fleming, “The eNOS signalosome and its link to endothelial dysfunction,” Pflügers Archiv, vol. 468, no. 7, pp. 1125–1137, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Dessy, O. Feron, and J. L. Balligand, “The regulation of endothelial nitric oxide synthase by caveolin: a paradigm validated in vivo and shared by the ‘endothelium-derived hyperpolarizing factor’,” Pflügers Archiv, vol. 459, no. 6, pp. 817–827, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. W. Kwok and M. G. Clemens, “Targeted mutation of Cav-1 alleviates the effect of endotoxin in the inhibition of ET-1-mediated eNOS activation in the liver,” Shock, vol. 33, no. 4, pp. 392–398, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Zhao, H. Li, L. L. Men et al., “Effects of selenoprotein S on oxidative injury in human endothelial cells,” Journal of Translational Medicine, vol. 11, no. 1, p. 287, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. H. N. Siti, Y. Kamisah, and J. Kamsiah, “The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review),” Vascular Pharmacology, vol. 71, pp. 40–56, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. F. Böhm and J. Pernow, “The importance of endothelin-1 for vascular dysfunction in cardiovascular disease,” Cardiovascular Research, vol. 76, no. 1, pp. 8–18, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. X. Sun, S. Kumar, S. Sharma et al., “Endothelin-1 induces a glycolytic switch in pulmonary arterial endothelial cells via the mitochondrial translocation of endothelial nitric oxide synthase,” American Journal of Respiratory Cell and Molecular Biology, vol. 50, no. 6, pp. 1084–1095, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Zenz, R. Eferl, C. Scheinecker et al., “Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease,” Arthritis Research & Therapy, vol. 10, no. 1, p. 201, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. J. F. Schindler, J. B. Monahan, and W. G. Smith, “p38 pathway kinases as anti-inflammatory drug targets,” Journal of Dental Research, vol. 86, no. 9, pp. 800–811, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. I. Pateras, C. Giaginis, C. Tsigris, E. Patsouris, and S. Theocharis, “NF-κB signaling at the crossroads of inflammation and atherogenesis: searching for new therapeutic links,” Expert Opinion on Therapeutic Targets, vol. 18, no. 9, pp. 1089–1101, 2014. View at Publisher · View at Google Scholar · View at Scopus